Sanofi Files Lawsuit Against Novo Nordisk for False Marketing

Dec 28, 2016


According to a Reuters article, Sanofi has filed a lawsuit in New Jersey accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its own diabetes drug.

The complaint was filed in U.S. District Court for the District of New Jersey on Dec. 23, and Sanofi wants Novo Nordisk to pay monetary damages and discontinue using those marketing materials for its drug Tresiba.

Read the Reuters story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments